|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-11-19
|
|
pubmed:abstractText |
The 5 fluorouracil hepato-arterial infusion (5-FU HAI) therapy has a good effect on the liver metastases of colorectal cancer. To gain the antitumor effect of the extra-hepatic lesion, an oral UFT was combined with 5-FU HAI (pharmacokinetic modulating chemotherapy, PMC) to enhance the plasma 5-FU concentration.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1743-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15553701-Administration, Oral,
pubmed-meshheading:15553701-Aged,
pubmed-meshheading:15553701-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15553701-Colorectal Neoplasms,
pubmed-meshheading:15553701-Drug Administration Schedule,
pubmed-meshheading:15553701-Fluorouracil,
pubmed-meshheading:15553701-Hepatic Artery,
pubmed-meshheading:15553701-Humans,
pubmed-meshheading:15553701-Infusions, Intra-Arterial,
pubmed-meshheading:15553701-Liver Neoplasms,
pubmed-meshheading:15553701-Male,
pubmed-meshheading:15553701-Middle Aged,
pubmed-meshheading:15553701-Neoplasm Metastasis,
pubmed-meshheading:15553701-Tegafur,
pubmed-meshheading:15553701-Uracil
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
|
|
pubmed:affiliation |
Dept. of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation Ohkubo Hospital.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
